MiR-501-3p in M2-Exos promotes tumor development by activating the transforming growth factor-β signaling pathway and inhibiting the tumor suppressor gene TGFBR3 (Yin et al., 2019). The gene discussed is TGFBR3; the disease is neoplasm.